06 Feb 2025
In a Bloomberg interview, Labcorp Chairman and CEO Adam Schechter discussed the company’s strong fourth-quarter performance and strategic direction for 2025. Schechter pointed to growth across diagnostics and drug development, driven by operational excellence and demand for innovative health solutions. He also emphasized Labcorp’s focus on expanding access and advancing science through strong partnerships. Watch the full interview on Bloomberg to learn more about Labcorp’s performance and future outlook.